by Brandon Tudor | Jun 3, 2025 | Uncategorized
Consider the article titled “Decompensated Liver Cirrhosis Care” from Gastroenterology & Endoscopy News (May 2025), which focuses on enhancing quality of life (QOL) and symptom management for patients with decompensated liver cirrhosis....
by Brandon Tudor | May 30, 2025 | Uncategorized
A recent study published in JAMA Surgery highlights the benefits of normothermic machine perfusion (NMP) in liver transplantation, particularly for organs from donation after circulatory death (DCD) donors. NMP involves preserving donor livers at body temperature with...
by Brandon Tudor | May 29, 2025 | Uncategorized
“The liver cirrhosis treatment market is poised for significant growth, driven by the rising global prevalence of liver diseases, particularly NAFLD, fueled by lifestyle factors like obesity, alcohol consumption, and metabolic syndrome. Technological...
by Brandon Tudor | May 24, 2025 | Uncategorized
“This nationwide study of pregnant women with MASLD confirms that MASLD should be regarded as a high-risk obstetric condition, carrying significant implications for pregnancy care,” the authors write. “Reassuringly, MASLD was not associated with abnormal birth weight...
by Brandon Tudor | May 21, 2025 | Uncategorized
Fascinating journal article here, titled “Electrocardiogram-based diagnosis of liver diseases: an externally validated and explainable machine learning approach.” [SOURCE: ScienceDirect]. The article explores the potential of using electrocardiogram (ECG)...
